Literature DB >> 26331814

Prevention and management of lung cancer in China.

Qun-Ying Hong1, Guo-Ming Wu2, Gui-Sheng Qian2, Cheng-Ping Hu3, Jian-Ying Zhou4, Liang-An Chen5, Wei-Min Li6, Shi-Yue Li7, Kai Wang8, Qi Wang9, Xiao-Ju Zhang10, Jing Li1, Xin Gong1, Chun-Xue Bai1,7.   

Abstract

Lung cancer is the leading cause of cancer-related death worldwide. In China, the incidence of lung cancer has grown rapidly, resulting in a large social and economic burden. Several researchers have devoted their studies to lung cancer and have demonstrated that there are many risk factors for lung cancer in China, including tobacco use, environmental pollution, food, genetics, and chronic obstructive pulmonary disease. However, the lung cancer incidence is still growing rapidly in China, and there is an even higher incidence among the younger generation. One explanation may be the triple-neglect situation, in which medical policies that neglect prevention, diagnosis, and supportive care have increased patients' mortality and reduced their quality of life. Therefore, it is necessary to enhance the efficiency of prevention and early diagnosis not only by focusing more attention on treatment but also by drawing more attention to supportive care for patients with lung cancer.
© 2015 American Cancer Society.

Entities:  

Keywords:  chronic obstructive pulmonary disease; lung cancer; management; prevention

Mesh:

Year:  2015        PMID: 26331814     DOI: 10.1002/cncr.29584

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  106 in total

1.  SP1-induced overexpression of LINC00520 facilitates non-small cell lung cancer progression through miR-577/CCNE2 pathway and predicts poor prognosis.

Authors:  Ji-Fang Wang; Zhuo-Na Xi; Hong-Jian Su; Zhen Bao; Ya-Hong Qiao
Journal:  Hum Cell       Date:  2021-03-11       Impact factor: 4.174

2.  Promoter methylation of TCF21 may repress autophagy in the progression of lung cancer.

Authors:  Baokun Chen; Chao Zeng; Yiwang Ye; Da Wu; Zhimin Mu; Jixian Liu; Yuancai Xie; Hao Wu
Journal:  J Cell Commun Signal       Date:  2017-10-30       Impact factor: 5.782

3.  Alterations of fecal bacterial communities in patients with lung cancer.

Authors:  Wei-Quan Zhang; Shu-Kang Zhao; Jun-Wen Luo; Xiao-Peng Dong; Ying-Tao Hao; Hui Li; Lei Shan; Yong Zhou; Hu-Bo Shi; Zai-Yun Zhang; Chuan-Liang Peng; Xiao-Gang Zhao
Journal:  Am J Transl Res       Date:  2018-10-15       Impact factor: 4.060

4.  Clinical profiles and trend analysis of newly diagnosed lung cancer in a tertiary care hospital of East China during 2011-2015.

Authors:  Pingli Wang; Jixia Zou; Jingni Wu; Chengyan Zhang; Chengxi Ma; Juan Yu; You Zhou; Baizhou Li; Kai Wang
Journal:  J Thorac Dis       Date:  2017-07       Impact factor: 2.895

5.  Transferrin-functionalised microemulsion co-delivery of β-elemene and celastrol for enhanced anti-lung cancer treatment and reduced systemic toxicity.

Authors:  Qian Zhang; Xin Tian; Xiufeng Cao
Journal:  Drug Deliv Transl Res       Date:  2019-06       Impact factor: 4.617

6.  Ubiquitin-specific protease 35 (USP35) mediates cisplatin-induced apoptosis by stabilizing BIRC3 in non-small cell lung cancer.

Authors:  Chunyan Liu; Zhaobo Chen; Xiaoyan Ding; Yun Qiao; Bing Li
Journal:  Lab Invest       Date:  2022-01-12       Impact factor: 5.662

7.  Major challenges in accurate mutation detection of multifocal lung adenocarcinoma by next-generation sequencing.

Authors:  Tian Qiu; Weihua Li; Fanshuang Zhang; Bingning Wang; Jianming Ying
Journal:  Cancer Biol Ther       Date:  2019-10-25       Impact factor: 4.742

8.  Chrysophanol exhibits anti-cancer activities in lung cancer cell through regulating ROS/HIF-1a/VEGF signaling pathway.

Authors:  Jie Zhang; Qian Wang; Qiang Wang; Peng Guo; Yong Wang; Yuqing Xing; Mengmeng Zhang; Fujun Liu; Qingyun Zeng
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-26       Impact factor: 3.000

9.  Feiyanning Formula Induces Apoptosis of Lung Adenocarcinoma Cells by Activating the Mitochondrial Pathway.

Authors:  Li-Min Zhu; Hai-Xia Shi; Masahiro Sugimoto; Kenjiro Bandow; Hiroshi Sakagami; Shigeru Amano; Hai-Bin Deng; Qing-Yu Ye; Yun Gai; Xiao-Li Xin; Zhen-Ye Xu
Journal:  Front Oncol       Date:  2021-07-02       Impact factor: 6.244

10.  Tumor Immune Microenvironment Characterization of Primary Lung Adenocarcinoma and Lymph Node Metastases.

Authors:  Yuan Zhou; Xinying Shi; Huan Chen; Beibei Mao; Xue Song; Lingling Gao; Jiao Zhang; Ying Yang; Henghui Zhang; Guo Wang; Wei Zhuang
Journal:  Biomed Res Int       Date:  2021-07-10       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.